Stephen E Gitelman

14PUBLICATIONS
64CO-AUTHORS
Pacific Peoples theory of change models for healthMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Infant and child healthAboriginal and Torres Strait Islander youth and family social and emotional wellbeing
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Sep 10, 2026
Preserving beta cell function in children and adolescents with newly diagnosed stage 3 type 1 diabetes: per-protocol population analysis from the PROTECT randomised trial.

|Mar 12, 2026
Beta cell glucose sensitivity identifies clinical response to disease-modifying therapies initiated at stage 3 type 1 diabetes onset.

Carmella Evans-Molina, Stephen E Gitelman, Andrea Mari

|Jan 21, 2026
Phase I Clinical Trial of Islet Antigen-Specific Plasmid Coexpressing Tolerogenic Proteins Demonstrates Safety in Adults With Type 1 Diabetes.

Carla J Greenbaum, S Alice Long, Stephen E Gitelman

|Nov 06, 2025
Safety and pharmacokinetics of teplizumab in children less than 8 years of age with stage 2 type 1 diabetes.

Stephen E Gitelman, Kimber Simmons, Jennifer L Sherr

|Feb 14, 2025
Real-world experiences of adult individuals or caregivers of children who received teplizumab treatment in stage 2 type 1 diabetes.

Holly K O'Donnell, Kimber M Simmons, Stephen E Gitelman

|May 08, 2024
A phase 2 randomized trial with autologous polyclonal expanded regulatory T cells in children with new-onset type 1 diabetes.

Christine Bender, Alice E Wiedeman, Alex Hu

Pageof 3

Frequent Collaborators

5 joint publications

Linda A DiMeglio

4 joint publications

Kevan C Herold

4 joint publications

Carmella Evans-Molina

4 joint publications

Kimber Simmons